Literature DB >> 22520521

Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.

Harvey D White1, Harmony R Reynolds, Antonio C Carvalho, Camille A Pearte, Li Liu, C Edwin Martin, Genell L Knatterud, Vladimír Džavík, Mariusz Kruk, Philippe Gabriel Steg, Warren J Cantor, Venu Menon, Gervasio A Lamas, Judith S Hochman.   

Abstract

BACKGROUND: The OAT study randomized 2,201 patients with a totally occluded infarct-related artery on days 3 to 28 (>24 hours) after myocardial infarction (MI) to percutaneous coronary intervention (PCI) or medical treatment (MED). There was no difference in the primary end point of death, reinfarction, or heart failure at 2.9 or 6-year mean follow-up. However, in patients randomized to PCI, there was a trend toward a higher rate of reinfarction.
METHODS: We analyzed the characteristics and types of reinfarction according to the universal definition. Independent predictors of reinfarction were determined using Cox proportional hazard models with follow-up up to 9 years.
RESULTS: There were 169 reinfarctions: 9.4% PCI vs 8.0% MED, hazard ratio 1.31, 95% CI 0.97-1.77, P = .08. Spontaneous reinfarction (type 1) occurred with similar frequency in the groups: 4.9% PCI vs 6.7% MED, hazard ratio 0.78, 95% CI 0.53-1.15, P = .21. Rates of type 2 (secondary) and 3 (sudden death) MI were similar in both groups. There was an increase in type 4a reinfarctions (related to protocol or other PCI) (0.8% PCI vs 0.1% MED, P = .01) and type 4b reinfarctions (stent thrombosis) (2.7% PCI vs 0.6% MED, P < .001). Multivariate predictors of reinfarction were history of PCI before study entry (P = .001), diabetes (P = .005), and absence of new Q waves with the index infarction (P = .01).
CONCLUSIONS: There was a trend for reinfarctions to be more frequent with PCI. Opening an occluded infarct-related artery in stable patients with late post-MI may expose them to a risk of subsequent reinfarction related to reocclusion and stent thrombosis.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22520521      PMCID: PMC4238915          DOI: 10.1016/j.ahj.2012.01.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

1.  Immediate changes of collateral function after successful recanalization of chronic total coronary occlusions.

Authors:  G S Werner; B M Richartz; O Gastmann; M Ferrari; H R Figulla
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

2.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

Authors:  Michael J Pencina; Ralph B D'Agostino
Journal:  Stat Med       Date:  2004-07-15       Impact factor: 2.373

3.  Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.

Authors:  Vladimír Dzavík; Christopher E Buller; Gervasio A Lamas; James M Rankin; G B John Mancini; Warren J Cantor; Ronald J Carere; John R Ross; Deborah Atchison; Sandra Forman; Boban Thomas; Pawel Buszman; Carlos Vozzi; Anthony Glanz; Eric A Cohen; Peter Meciar; Gerald Devlin; Alice Mascette; George Sopko; Genell L Knatterud; Judith S Hochman
Journal:  Circulation       Date:  2006-11-14       Impact factor: 29.690

4.  Design and methodology of the Occluded Artery Trial (OAT).

Authors:  Judith S Hochman; Gervasio A Lamas; Genell L Knatterud; Christopher E Buller; Vladimir Dzavik; Daniel B Mark; Harmony R Reynolds; Harvey D White
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

5.  Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound.

Authors:  Italo Porto; Joseph B Selvanayagam; William J Van Gaal; Francesco Prati; Adrian Cheng; Keith Channon; Stefan Neubauer; Adrian P Banning
Journal:  Circulation       Date:  2006-08-07       Impact factor: 29.690

6.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors:  Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Coronary intervention for persistent occlusion after myocardial infarction.

Authors:  Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; P Gabriel Steg; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud
Journal:  N Engl J Med       Date:  2006-11-14       Impact factor: 91.245

8.  The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction.

Authors:  Gerald S Werner; Ralf Surber; Markus Ferrari; Michael Fritzenwanger; Hans R Figulla
Journal:  Eur Heart J       Date:  2006-09-26       Impact factor: 29.983

9.  Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.

Authors:  Judith S Hochman; Harmony R Reynolds; Vladimír Dzavík; Christopher E Buller; Witold Ruzyllo; Zygmunt P Sadowski; Aldo P Maggioni; Antonio C Carvalho; James M Rankin; Harvey D White; Suzanne Goldberg; Sandra A Forman; Daniel B Mark; Gervasio A Lamas
Journal:  Circulation       Date:  2011-10-24       Impact factor: 29.690

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  19 in total

1.  Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment.

Authors:  Ramin S Hastings; Judith S Hochman; Vladimir Dzavik; Gervasio A Lamas; Sandra A Forman; Francois Schiele; Lampros K Michalis; Dimitris Nikas; Joanna Jaroch; Harmony R Reynolds
Journal:  Am J Cardiol       Date:  2012-06-22       Impact factor: 2.778

2.  Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.

Authors:  Kris G Vargas; Paul M Haller; Bernhard Jäger; Maximilian Tscharre; Ronald K Binder; Christian Mueller; Bertil Lindahl; Kurt Huber
Journal:  Clin Res Cardiol       Date:  2018-12-07       Impact factor: 5.460

3.  Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.

Authors:  Qiaomei Jin; Juanzhi Zhao; Meng Gao; Yuanbo Feng; Wei Liu; Zhiqi Yin; Tiannv Li; Shaoli Song; Yicheng Ni; Jian Zhang; Dejian Huang; Dongjian Zhang
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

4.  Fibroblast KATP currents modulate myocyte electrophysiology in infarcted hearts.

Authors:  Najate Benamer; Carolina Vasquez; Vanessa M Mahoney; Maximilian J Steinhardt; William A Coetzee; Gregory E Morley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-22       Impact factor: 4.733

Review 5.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

6.  Evaluation of Radioiodinated 1,4-Naphthoquinones as Necrosis Avid Agents for Rapid Myocardium Necrosis Imaging.

Authors:  Chang Su; Dongjian Zhang; Na Bao; Aiyan Ji; Yuanbo Feng; Li Chen; Yicheng Ni; Jian Zhang; Zhiqi Yin
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

7.  Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction.

Authors:  Nathaniel R Smilowitz; Pritha Subramanyam; Eugenia Gianos; Harmony R Reynolds; Binita Shah; Steven P Sedlis
Journal:  Coron Artery Dis       Date:  2018-01       Impact factor: 1.439

Review 8.  Universal MI definition update for cardiovascular disease.

Authors:  Harvey White; Kristian Thygesen; Joseph S Alpert; Allan Jaffe
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

9.  Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.

Authors:  Christopher Adlbrecht; Kurt Huber; Harmony R Reynolds; Antonio C Carvalho; Vladimír Džavík; Philippe Gabriel Steg; Li Liu; Paolo Marino; Camille A Pearte; James M Rankin; Harvey D White; Gervasio A Lamas; Judith S Hochman
Journal:  Int J Cardiol       Date:  2014-03-28       Impact factor: 4.164

10.  Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.

Authors:  Junjie Yang; David W Biery; Avinainder Singh; Sanjay Divakaran; Ersilia M DeFilippis; Wanda Y Wu; Josh Klein; Jon Hainer; Mattheus Ramsis; Pradeep Natarajan; James L Januzzi; Khurram Nasir; Deepak L Bhatt; Marcelo F Di Carli; Ron Blankstein
Journal:  Am J Med       Date:  2019-11-09       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.